Medline Inc.

Medline Inc.

MDLN
Medline Inc.US flagNASDAQ Global Select
35.31
USD
-0.15
- -
30.98BMarket Cap
Medline Inc.
MDLN
(NASDAQ Global Select)

Recent

price

35.31

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
TTM
FRC
- -
- -
- -
35.1
21.16
Revenue per Share
- -
- -
- -
1.43
0.34
Basic EPS, GAAP
- -
-0.15
- -
1.6
0.94
Free Cash Flow per Basic Share
- -
- -
- -
0.64
0.09
Dividend per Share
- -
- -
- -
13.22
13.19
Book Value per Share
- -
- -
- -
-13.84
-11.45
Tangible Book Value per Share
1,828
1,828
1,828
810
1,078
Basic Weighted Avg Shares
- -
- -
- -
28,432
22,824
Sales/Revenue/Turnover
- -
- -
- -
7.78
5.44
Operating Margin (%)
- -
- -
- -
1,011
771
Depreciation Expense
- -
- -
- -
1,159
371
Net Income, GAAP
- -
- -
- -
7.29
23.77
Effective Tax Rate (%)
- -
- -
- -
4.08
1.63
Profit Margin (%)
- -
- -
- -
8,189
9,032
Working Capital
- -
- -
- -
12,484
12,548
LT Debt
- -
- -
- -
19,286
19,077
Total Equity
- -
- -
- -
12.87
5.98
Return on Invested Capital (%)
- -
- -
- -
11.99
3.55
Return on Capital (%)
- -
- -
- -
21.59
6.41
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
143
142
92
LT Borrowings
12,484
12,495
12,548
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
812
846
877
Market Capitalization
34,104
37,647
34,589

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
10,679
11,180
11,742
Cash, Cash Equivalents & STI
1,939
2,236
2,677
Accounts Receivable, Net
3,533
3,674
3,661
Inventories
4,769
4,807
4,665
Total Current Liabilities
2,490
2,536
2,710
Payables & Accruals
1,945
1,994
2,104
ST Debt
143
142
92
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
-571.64%
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
6,644
- -
- -
7,787
28,432
2026
7,352
7,685
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
0.18
- -
- -
0.22
1.43
2026
0.16
0.07
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
0.12
0.64
2026
- -
- -
- -
- -
- -
Business
Medline Industries, Inc. operates as a leading healthcare supply company that manufactures, distributes, and distributes and sources medical and surgical products to healthcare institutions, home health, hospice, physician offices, and related care settings worldwide. Founded in 1966 and headquartered in Northfield, Illinois, Medline expands its footprint through a broad product portfolio and global distribution network to serve hospitals, clinics, long-term care facilities, and homecare providers across North America, Europe, the Middle East, Africa, and Latin America. Main products and services - Core product categories: medical and surgical supplies; skin care, wound care, and incontinence products; infection prevention solutions; nursing and patient care disposables; gloves, textiles, and apparel; nutrition and enteral feeding supplies; respiratory and anesthesia products; central sterile and sterilization solutions; beds, mattresses, and patient furniture; medical furniture and equipment; clinical textiles and laundry services. - Surgical solutions and instruments: surgical instruments and related disposables; sterile drapes and packs; sterile processing supplies; operating room integration products; single-use devices and consumables for procedures. - Healthcare equipment and technology: patient monitoring basics, mobility aids, hospital beds and mattresses, clinical electronics and basic instrumentation; equipment rentals and service offerings in some markets. - Private label and custom solutions: private-label product lines; supply chain optimization services; category management and procurement outsourcing; healthcare facility consulting and workflow optimization. - Distribution and services: nationwide and international distribution across multiple fulfillment centers; inventory management; order processing; just-in-time delivery; training and assistance with product implementation and infection control programs. Latest major company changes - Strategic expansion of product offerings through acquisitions (notably broadening sterile drape and surgical solutions portfolio) and ongoing international expansion to increase global market reach. - Strengthening end-to-end supply chain capabilities with enhanced private-label options and supplier consolidation to improve cost efficiency and service levels. - Introduction of expanded sterile processing and temperature-management product lines as part of a broader operating room solutions strategy. - Ongoing investments in international markets, including expansion of regional branches and distribution networks to support growth outside North America. - Leadership and organizational realignments to support rapid growth and integration of acquired product lines and new markets. Additional context - Industry and segments: healthcare supplies and equipment; hospital and clinical supply distribution; infection prevention and wound care; medical-surgical products; centralized sterile and operating room solutions. - Target markets: hospitals and health systems, ambulatory surgery centers, long-term care facilities, home health agencies, physician offices, and managed care organizations. - Geographic operations: strong presence in North America with growing international footprint in Europe, Middle East, Africa, and Latin America; regional offices and distribution centers support global logistics. - Corporate structure: private company with a broad network of distribution centers; operates with a centralized sourcing and distribution model to support large healthcare customers. - Subsidiaries/affiliates: operates a network of regional subsidiaries and distribution affiliates to service various geographic markets and customer segments.

Company News

  • MDLN Loss Notice: Medline Investors are Reminded of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • MDLN Investigation Reminder: Medline Investors that Lost Money after the 13% Stock Drop are Notified to Contact BFA Law

  • Medline $MDLN Stock Acquired by Banque Pictet & Cie SA

  • MDLN Securities Announcement: Medline Investors with Losses may have Rights in an Ongoing Securities Fraud Investigation – Contact BFA Law

  • Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • $MDLN Investors: A Securities Fraud Investigation is Pending on behalf of Medline Investors that Lost Money after 13% Stock Drop – Contact BFA Law

  • Medline Inc. Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your MDLN Investments

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors

  • Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care

  • Critical Survey: Medline (NASDAQ:MDLN) & NovoCure (NASDAQ:NVCR)

  • MDLN Securities Alert: Lose Money on Your Medline Investment? BFA Law Notifies Investors of the Ongoing Securities Fraud Investigation over Product Quality Issues

  • MDLN ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Potential Securities Law Violations

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • Medline (NASDAQ:MDLN) Stock: Insider Private Ltd Gic Sells 2,570,999 Shares

  • MDLN Investor Reminder: BFA Law Reminds Medline Investors that Lost Money when Stock Dropped 13% of the Ongoing Securities Fraud Investigation

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Medline Inc. - MDLN

  • Kaplan Fox is Investigating Medline Inc. (MDLN) for Investors Who Suffered Losses